Home - BBC News
Visit BBC News for up-to-the-minute news, breaking news, video, audio and feature stories. BBC News provides trusted World and UK news as well as local and regional perspectives.
Beta Bionic, Inc. (BBNX) Stock Price, Quote & News - Stock Analysis
Get the latest Beta Bionic, Inc. (BBNX) stock price quote with news, financials, IPO details and other important investing information.
BBNX Beta Bionics, Inc. - Seeking Alpha
A high-level overview of Beta Bionics, Inc. (BBNX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Beta Bionics, Inc. (BBNX) Announces January 30th IPO - ETF Daily News
1 day ago · Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares …
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing
3 days ago · Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m …
Beta Bionics sets terms for upsized $113M IPO (BBNX:Pending)
4 days ago · Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering. Read more here.
BBNX IPO News - Insulin delivery device maker Beta Bionics files …
Jan 6, 2025 · Beta Bionics' iLet Bionic Pancreas (iLet) is the first insulin delivery device cleared by the FDA to utilize adaptive closed-loop algorithms to autonomously determine every insulin …
Diabetes device maker Beta Bionics files for $100M IPO
Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. Read more here.
Beta Bionic (BBNX) Files for Proposed IPO - streetinsider.com
(Updated - January 6, 2025 4:28 PM EST) Beta Bionic (NASDAQ: BBNX) has filed for a proposed IPO.
BBNX IPO News - Insulin delivery device maker Beta Bionics sets …
5 days ago · Beta Bionics, which makes an automated insulin delivery system for type 1 diabetes, announced terms for its IPO on Wednesday.
- Some results have been removed